Atea Pharmaceuticals, Inc. AVIR Q2 2025 earnings
Reported August 7, 2025 · After market close
EPS estimate-$0.46
Next report
Aug 6, 2026 (In 3 weeks)Revenue estimate$33.0M
EPS estimate-$0.56
Versus estimates
Diluted EPS
Ask the moment Atea Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Atea Pharmaceuticals, Inc. report Q2 2025 earnings?
- Atea Pharmaceuticals, Inc. (AVIR) reported Q2 2025 earnings on August 7, 2025 after market close.
- What were Atea Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
- Atea Pharmaceuticals, Inc. reported diluted EPS of $-0.44 for Q2 2025.
- Did Atea Pharmaceuticals, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.46 by $0.02.
- How did Atea Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 8.3% from $-0.48.
- Where can I find Atea Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-105123) directly on SEC EDGAR. The filing index links above go to sec.gov.